4//SEC Filing
Yu Li 4
Accession 0001493152-21-025423
CIK 0001642380other
Filed
Oct 13, 8:00 PM ET
Accepted
Oct 14, 4:05 PM ET
Size
5.9 KB
Accession
0001493152-21-025423
Insider Transaction Report
Form 4
Yu Li
VP Cntrllr/Prncpl Acctng Offcr
Transactions
- Award
Option to Purchase Common Stock
2021-06-24+160,000→ 160,000 totalExercise: $4.33Exp: 2031-05-18→ Common Stock (160,000 underlying)
Footnotes (2)
- [F1]This option award was granted on May 18, 2021, but such award was subject to shareholder approval of an increase in the number of shares available for issuance under the Oncocyte 2018 Equity Incentive Plan. Such shareholder approval was received on June 24, 2021.
- [F2]25% of the options will become exercisable after one year of continuous employment from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to continued employment on the applicable vesting date.
Documents
Issuer
Oncocyte Corp
CIK 0001642380
Entity typeother
Related Parties
1- filerCIK 0001777275
Filing Metadata
- Form type
- 4
- Filed
- Oct 13, 8:00 PM ET
- Accepted
- Oct 14, 4:05 PM ET
- Size
- 5.9 KB